These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

477 related items for PubMed ID: 33084541

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Elevated PHD2 expression might serve as a valuable biomarker of poor prognosis in lung adenocarcinoma, but no lung squamous cell carcinoma.
    Xu XL, Gong Y, Zhao DP.
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8731-8739. PubMed ID: 30575913
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A prognosis-related molecular subtype for early-stage non-small lung cell carcinoma by multi-omics integration analysis.
    Yang K, Wu Y.
    BMC Cancer; 2021 Feb 06; 21(1):128. PubMed ID: 33549049
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation.
    Zheng Q, Wang Z, Zhang M, Yu Y, Chen R, Lu T, Liu L, Ma J, Liu T, Zheng H, Li H, Li J.
    BMC Cancer; 2021 Nov 13; 21(1):1216. PubMed ID: 34774014
    [Abstract] [Full Text] [Related]

  • 8. USP4 expression independently predicts favorable survival in lung adenocarcinoma.
    Zhong M, Jiang Q, Jin R.
    IUBMB Life; 2018 Jul 13; 70(7):670-677. PubMed ID: 29667299
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. System analysis of FHIT in LUAD and LUSC: The expression, prognosis, gene regulation network, and regulation targets.
    Situ Y, Gao R, Lei L, Deng L, Xu Q, Shao Z.
    Int J Biol Markers; 2022 Jun 13; 37(2):158-169. PubMed ID: 35254116
    [Abstract] [Full Text] [Related]

  • 11. Exploring and comparing of the gene expression and methylation differences between lung adenocarcinoma and squamous cell carcinoma.
    Yang Y, Wang M, Liu B.
    J Cell Physiol; 2019 Apr 13; 234(4):4454-4459. PubMed ID: 30317601
    [Abstract] [Full Text] [Related]

  • 12. LDHA upregulation independently predicts poor survival in lung adenocarcinoma, but not in lung squamous cell carcinoma.
    Yu C, Hou L, Cui H, Zhang L, Tan X, Leng X, Li Y.
    Future Oncol; 2018 Oct 13; 14(24):2483-2492. PubMed ID: 29756998
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. NFIX downregulation independently predicts poor prognosis in lung adenocarcinoma, but not in squamous cell carcinoma.
    Ge J, Dong H, Yang Y, Liu B, Zheng M, Cheng Q, Peng L, Li J.
    Future Oncol; 2018 Dec 13; 14(30):3135-3144. PubMed ID: 30418046
    [Abstract] [Full Text] [Related]

  • 15. Increased GOLM1 Expression Independently Predicts Unfavorable Overall Survival and Recurrence-Free Survival in Lung Adenocarcinoma.
    Liu X, Chen L, Zhang T.
    Cancer Control; 2018 Dec 13; 25(1):1073274818778001. PubMed ID: 29843532
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. High KRT8 Expression Independently Predicts Poor Prognosis for Lung Adenocarcinoma Patients.
    Xie L, Dang Y, Guo J, Sun X, Xie T, Zhang L, Yan Z, Amin H, Guo X.
    Genes (Basel); 2019 Jan 10; 10(1):. PubMed ID: 30634629
    [Abstract] [Full Text] [Related]

  • 18. SPC25 upregulation increases cancer stem cell properties in non-small cell lung adenocarcinoma cells and independently predicts poor survival.
    Chen J, Chen H, Yang H, Dai H.
    Biomed Pharmacother; 2018 Apr 10; 100():233-239. PubMed ID: 29432994
    [Abstract] [Full Text] [Related]

  • 19. Differential prognostic impact and potential molecular mechanisms of PCDHGA12 expression in lung adenocarcinoma and squamous cell carcinoma.
    Xu X, Zhang J, Yao T, Zhao X, Wu Q, Lu C, Guo X, Xie S, Qiu L, Bi R, Xue H.
    Int Immunopharmacol; 2024 Sep 30; 139():112727. PubMed ID: 39067405
    [Abstract] [Full Text] [Related]

  • 20. Elevated Expression of LYPD3 Is Associated with Lung Adenocarcinoma Carcinogenesis and Poor Prognosis.
    Hu P, Huang Y, Gao Y, Yan H, Li X, Zhang J, Wang Y, Zhao Y.
    DNA Cell Biol; 2020 Apr 30; 39(4):522-532. PubMed ID: 32040344
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.